PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.\', \'Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Department of Otolaryngology, Head and Neck Surgery, Radboudumc, 6500 HB Nijmegen, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 28210.3390/v13020282
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 33670363
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all